Anzeige
Mehr »
Login
Mittwoch, 05.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
Geheime Erdgas-Perle: Horizon Petroleum startet Lachowice-Projekt: Aktie vor neuem Höhenflug?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 03.01.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
03.01.Q-linea AB: Q-linea resolves on the terms for a rights issue of approximately SEK 225 million456Q-linea AB (publ) ("Q-linea" or the "Company") announces that the board of directors today has resolved on the terms for the planned rights issue of units with preferential rights for the Company's...
► Artikel lesen
03.01.CIS acquires Acuitive's AcuAudit-
03.01.Swissport handles SKYhigh cargo at Miami Airport-
03.01.Air France KLM Cargo sets new online booking record4
03.01.Polar Light achieves 625nm-wavelength red pyramidal micro-LED-
03.01.Could software license costs be the key to AMD's server takeover?-
03.01.With changes looming, NTIA sets the record straight on alternate BEAD tech-
03.01.Here's what 2025 has in store for private 5G deployments-
03.01.Aetna's network contract with Providence expires amid protracted negotiations-
03.01.Aetna sues drugmakers for widespread price-fixing and collusion-
03.01.Healthcare poised for 'robust' M&A activity in 2025: PwC-
03.01.Study sparks call for funding reforms to protect patient groups from pharma influence-
03.01.Astellas, Endo issue US drug recalls over empty capsule, ingredient concerns1
03.01.CRO Veeda unveils 'modern and dynamic' rebrand to mirror expansion into CDMO services-
03.01.BioNTech inks settlements with NIH, Penn in COVID-19 vaccine royalty disputes1
03.01.Roche projected to claim pharma's 2025 sales crown as Novo, Lilly climb rankings: Evaluate6
03.01.Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row-
03.01.iBio pens $29M biobucks deal with AstralBio for obesity med designed to preserve muscle mass1
03.01.Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'-
03.01.Investor pumps $3M into cash-strapped Cyclacel in return for CEO role-
Seite:  Weiter >>